Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bardelli

Showing results (161-170 of 281) with videos related to

Pageof 29
Sort By:
Cancer Treatment Reviews|January 8, 2019
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategiesGianluca Mauri, Elio Gregory Pizzutilo, Alessio Amatu, et al.
Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Nature Communications|September 23, 2015
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancersSandra Misale, Ivana Bozic, Jingshan Tong, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Science Translational Medicine|February 21, 2014
Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancerSandra Misale, Sabrina Arena, Simona Lamba, et al.
Cancer Discovery|March 3, 2021
CD4 T Cell-Dependent Rejection of Beta-2 Microglobulin Null Mismatch Repair-Deficient TumorsGiovanni Germano, Steve Lu, Giuseppe Rospo, et al.
Science (New York, N.Y.)|March 16, 2004
High frequency of mutations of the PIK3CA gene in human cancersYardena Samuels, Zhenghe Wang, Alberto Bardelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2004
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patientsTian-Li Wang, Luis A Diaz, Katharine Romans, et al.
Pageof 29

Showing results (161-170 of 281) with videos related to

Sort By:
Pageof 29
Cancer Treatment Reviews|January 8, 2019
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategiesGianluca Mauri, Elio Gregory Pizzutilo, Alessio Amatu, et al.
Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Nature Communications|September 23, 2015
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancersSandra Misale, Ivana Bozic, Jingshan Tong, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Science Translational Medicine|February 21, 2014
Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancerSandra Misale, Sabrina Arena, Simona Lamba, et al.
Cancer Discovery|March 3, 2021
CD4 T Cell-Dependent Rejection of Beta-2 Microglobulin Null Mismatch Repair-Deficient TumorsGiovanni Germano, Steve Lu, Giuseppe Rospo, et al.
Science (New York, N.Y.)|March 16, 2004
High frequency of mutations of the PIK3CA gene in human cancersYardena Samuels, Zhenghe Wang, Alberto Bardelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2004
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patientsTian-Li Wang, Luis A Diaz, Katharine Romans, et al.
Pageof 29